Through the same mechanisms, the treatment with anti-TGF-β reduced tumor growth in vivo in an azoxymethane (AOM) and dextran sulfate sodium (DSS) induced colon rectal cancer mouse model [132]. Here, TGFB1 is linked to neoplasm.